Drug Trial Radar · NCT01872689
A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Last checked: Nov 19, 2026Latest source record: Aug 24, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
505
Actual
Start
Oct 13, 2013
Primary completion
Jul 28, 2017
Study completion Nov 6, 2017
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Jun 7, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized, multicenter, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of lebrikizumab as monotherapy in the absence of background IPF therapy and as combination therapy with pirfenidone background therapy in participants with IPF. Participants will be randomized to receive either lebrikizumab or placebo subcutaneously every 4 weeks.
Conditions
- Idiopathic Pulmonary Fibrosis
Interventions
LebrikizumabDrug
Lebrikizumab will be administered at a dose of 250 mg via SC injection once every 4 weeks.
PirfenidoneDrug
Pirfenidone will be administered orally at a stable dose of 2403 mg per day or at MTD.
PlaceboDrug
Placebo matched to lebrikizumab will be administered via SC injection once every 4 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Rate of Decrease in Percent Predicted Forced Vital Capacity (FVC) Over 52 WeeksTime frame: Baseline up to Week 52 (assessed at Baseline, Weeks 1, 4, 12, 24, 36, 44, and 52)
Locations
112 sites in 13 countries. Site status is shown where the registry gives one.
University Alabama At Birmingham
Birmingham, Alabama
Mayo Clinic- Scottsdale
Scottsdale, Arizona
Southern Arizona Veterans Administration Healthcare Systems
Tucson, Arizona
University of Arizona
Tucson, Arizona
UCSD Medical Center
La Jolla, California
University of California, San Francisco
San Francisco, California
National Jewish Health
Denver, Colorado
Rocky Mountain Center For Clinical Research
Wheat Ridge, Colorado
Yale New Haven Hospital
New Haven, Connecticut
Research Alliance Inc
Clearwater, Florida
Mayo Clinic-Jacksonville
Jacksonville, Florida
University Miami
Miami, Florida
Central Florida Pulmonary Group, PA
Orlando, Florida
USF Tampa General Hospital
Tampa, Florida
Cleveland Clinic Florida
Weston, Florida
Piedmont Healthcare Pulmonary and Critical Care Research
Austell, Georgia
Southeastern Lung Care
Decatur, Georgia
University of Chicago; Pulmonary and Critical Care
Chicago, Illinois
Loyola University Med Center
Maywood, Illinois
Univ of Iowa Hosp & Clinics; Pulmonary
Iowa City, Iowa
Uni of Kansas Medical Center
Kansas City, Kansas
Via Christi Hospital Inc. DBA Via Christi Research; Research Dept.
Wichita, Kansas
Maine Medical Center -Division of Pulmomary and Critical Care Medicine
Portland, Maine
University of Maryland Medical Center
Baltimore, Maryland
Johns Hopkins Bayview Medical Center - Johns Hopkins Asthma & Allergy Center
Baltimore, Maryland
Tufts Medical Center
Boston, Massachusetts
University of Minnesota Hospital & Clinic
Minneapolis, Minnesota
Mayo Clinic Rochester
Rochester, Minnesota
Cardiopulmonary Associates LLC Cardiopulmonary Research
Chesterfield, Missouri
University of Nebraska
Omaha, Nebraska
Lovelace Scientific Resources, Inc.
Albuquerque, New Mexico
Weill Medical College of Cornell University
New York, New York
Mt Sinai School Medical Pulmo And Critical Care Med
New York, New York
Highland Hospital-University of Rochester Medical Center
Rochester, New York
University of Cincinnati
Cincinnati, Ohio
Case Western Research University; University Hospitals Case Medical Center
Cleveland, Ohio
Ohio State University
Columbus, Ohio
Oklahoma University Health Sciences Center
Oklahoma City, Oklahoma
The Oregon Clinic.
Portland, Oregon
Penn State University College Medical Allergy And Care Med
Hershey, Pennsylvania
Showing 40 of 112 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.